Combined administration of anti‐IL‐13 and anti‐IL‐17A at individually sub‐therapeutic doses limits asthma‐like symptoms in a mouse model of Th2/Th17 high asthma

Clinical &Experimental Allergy, Volume 0, Issue ja, -Not available-.


https://ift.tt/2yZORGT